UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in MNKD — Mannkind Corp
CIK 861177
NEW YORK, NY
Position in MNKD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,288,188
-$731,782 QoQ
Shares Held
537,134
-56.4% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 254 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 37%
Shared 0%
None 63%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. MNKD ranks #93 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in MNKD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,288,188 | 537,134 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,019,970 | 1,232,642 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $6,174,960 | 1,089,059 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,695,151 | 501,891 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,476,588 | 929,570 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,374,482 | 670,872 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $3,971,614 | 617,670 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,626,358 | 576,528 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,405,232 | 652,344 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,711,966 | 377,918 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,375,618 | 377,918 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,464,243 | 354,539 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,389,313 | 341,355 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,399,553 | 341,355 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $774,949 | 250,793 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,008,372 | 264,665 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $973,966 | 264,665 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,183,915 | 270,919 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,178,496 | 270,919 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,476,507 | 270,919 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||